Cargando…
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
MSCs products as well as their derived extracellular vesicles, are currently being explored as advanced biologics in cell-based therapies with high expectations for their clinical use in the next few years. In recent years, various strategies designed for improving the therapeutic potential of mesen...
Autores principales: | Fernández-Santos, Maria Eugenia, Garcia-Arranz, Mariano, Andreu, Enrique J., García-Hernández, Ana Maria, López-Parra, Miriam, Villarón, Eva, Sepúlveda, Pilar, Fernández-Avilés, Francisco, García-Olmo, Damian, Prosper, Felipe, Sánchez-Guijo, Fermin, Moraleda, Jose M., Zapata, Agustin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261977/ https://www.ncbi.nlm.nih.gov/pubmed/35812460 http://dx.doi.org/10.3389/fimmu.2022.918565 |
Ejemplares similares
-
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
por: Sánchez-Guijo, Fermín, et al.
Publicado: (2020) -
Autologous adipose‐derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long‐term follow‐up
por: Garcia‐Arranz, Mariano, et al.
Publicado: (2019) -
Exofucosylation of Adipose Mesenchymal Stromal Cells Alters Their Secretome Profile
por: García-Bernal, David, et al.
Publicado: (2020) -
The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
por: García-Bernal, David, et al.
Publicado: (2021) -
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
por: Soria-Juan, Barbara, et al.
Publicado: (2021)